These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
550 related articles for article (PubMed ID: 27316347)
1. Targeting histone methylation for cancer therapy: enzymes, inhibitors, biological activity and perspectives. Song Y; Wu F; Wu J J Hematol Oncol; 2016 Jun; 9(1):49. PubMed ID: 27316347 [TBL] [Abstract][Full Text] [Related]
2. Epigenetic small molecule modulators of histone and DNA methylation. Hauser AT; Robaa D; Jung M Curr Opin Chem Biol; 2018 Aug; 45():73-85. PubMed ID: 29579619 [TBL] [Abstract][Full Text] [Related]
3. Targeting Histone Methylation in Cancer. McCabe MT; Mohammad HP; Barbash O; Kruger RG Cancer J; 2017; 23(5):292-301. PubMed ID: 28926430 [TBL] [Abstract][Full Text] [Related]
4. Targeting histone methyltransferases and demethylases in clinical trials for cancer therapy. Morera L; Lübbert M; Jung M Clin Epigenetics; 2016; 8():57. PubMed ID: 27222667 [TBL] [Abstract][Full Text] [Related]
8. Epigenetic Targets and their Inhibitors in Cancer Therapy. Zhao L; Duan YT; Lu P; Zhang ZJ; Zheng XK; Wang JL; Feng WS Curr Top Med Chem; 2018; 18(28):2395-2419. PubMed ID: 30582481 [TBL] [Abstract][Full Text] [Related]
9. Modifications of histones in parasites as drug targets. Nawaz M; Malik I; Hameed M; Hussain Kuthu Z; Zhou J Vet Parasitol; 2020 Feb; 278():109029. PubMed ID: 31978703 [TBL] [Abstract][Full Text] [Related]
10. Exploring Methods of Targeting Histone Methyltransferases and Their Applications in Cancer Therapeutics. Wang MY; Liow P; Guzman MIT; Qi J ACS Chem Biol; 2022 Apr; 17(4):744-755. PubMed ID: 35363464 [TBL] [Abstract][Full Text] [Related]
11. Inhibitors of enzymes catalyzing modifications to histone lysine residues: structure, function and activity. Lillico R; Stesco N; Khorshid Amhad T; Cortes C; Namaka MP; Lakowski TM Future Med Chem; 2016 May; 8(8):879-97. PubMed ID: 27173004 [TBL] [Abstract][Full Text] [Related]
12. Reversing aberrant methylation patterns in cancer. Poke FS; Qadi A; Holloway AF Curr Med Chem; 2010; 17(13):1246-54. PubMed ID: 20166939 [TBL] [Abstract][Full Text] [Related]
13. DNA Methylation Targeting: The DNMT/HMT Crosstalk Challenge. Castillo-Aguilera O; Depreux P; Halby L; Arimondo PB; Goossens L Biomolecules; 2017 Jan; 7(1):. PubMed ID: 28067760 [TBL] [Abstract][Full Text] [Related]
14. The emerging therapeutic potential of histone methyltransferase and demethylase inhibitors. Spannhoff A; Hauser AT; Heinke R; Sippl W; Jung M ChemMedChem; 2009 Oct; 4(10):1568-82. PubMed ID: 19739196 [TBL] [Abstract][Full Text] [Related]
15. Protein Lysine Methyltransferases Inhibitors. Li Y; Ding L; Ren S; Zhang W; Rao GW Curr Med Chem; 2023; 30(27):3060-3089. PubMed ID: 36043747 [TBL] [Abstract][Full Text] [Related]
16. Epigenetic targets and drug discovery: part 1: histone methylation. Liu Y; Liu K; Qin S; Xu C; Min J Pharmacol Ther; 2014 Sep; 143(3):275-94. PubMed ID: 24704322 [TBL] [Abstract][Full Text] [Related]
18. Epigenetic cancer therapy: Proof of concept and remaining challenges. Mund C; Lyko F Bioessays; 2010 Nov; 32(11):949-57. PubMed ID: 21154865 [TBL] [Abstract][Full Text] [Related]
19. Screening for compounds that modulate epigenetic regulation of the transcriptome: an overview. Eglen RM; Reisine T J Biomol Screen; 2011 Dec; 16(10):1137-52. PubMed ID: 22002420 [TBL] [Abstract][Full Text] [Related]
20. Histone methyltransferase inhibitors: novel epigenetic agents for cancer treatment. Zagni C; Chiacchio U; Rescifina A Curr Med Chem; 2013; 20(2):167-85. PubMed ID: 23210854 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]